Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer

Niranjan J. Sathianathen, Yiannis A. Philippou, Gretchen M. Kuntz, Badrinath R. Konety, Alastair D. Lamb, Philipp Dahm

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
Original languageEnglish (US)
Article numberCD012816
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number9
DOIs
StatePublished - Sep 30 2017

Fingerprint Dive into the research topics of 'Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer'. Together they form a unique fingerprint.

  • Cite this